These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23484777)

  • 1. Voriconazole induced bradycardia.
    Uludağ D; Ozdemir N; Tüysüz G; Eroğlu AG; Celkan T
    Pediatr Hematol Oncol; 2013 Oct; 30(7):674-6. PubMed ID: 23484777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole-associated severe hyponatremia.
    Kim KH; Lee S; Lee S; Yun NR; Kim NJ; Yu KS; Jang IJ; Park WB; Oh MD
    Med Mycol; 2012 Jan; 50(1):103-5. PubMed ID: 21671829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
    Chow E; Moore T; Nielsen K
    Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
    Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
    Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
    Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
    Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
    [No Abstract]   [Full Text] [Related]  

  • 7. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
    J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole-associated myositis.
    Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
    J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
    Kohno S; Ogawa K; Kurashima A; Niki Y; Maesaki S
    Jpn J Antibiot; 2007 Dec; 60(6):321-34. PubMed ID: 18447204
    [No Abstract]   [Full Text] [Related]  

  • 13. Voriconazole-induced retinoid-like photosensitivity in children.
    Rubenstein M; Levy ML; Metry D
    Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoporphyria as a result of voriconazole use: a case report.
    Dolan CK; Hall MA; Blazes DL; Norwood CW
    Int J Dermatol; 2004 Oct; 43(10):768-71. PubMed ID: 15485539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
    Heinz WJ; Silling G; Böhme A
    Curr Med Res Opin; 2011 Feb; 27(2):335-42. PubMed ID: 21155707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
    Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH
    Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
    Molina JR; Serrano J; Sánchez-García J; Rodríguez-Villa A; Gómez P; Tallón D; Martín V; Rodríguez G; Rojas R; Martín C; Martínez F; Alvarez MA; Torres A
    Bone Marrow Transplant; 2012 Apr; 47(4):562-7. PubMed ID: 21572466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
    Philip A; Sivaprakasam P; Sagar TG; Ganesan P
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):406. PubMed ID: 22713708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.